Skip to main content
Erschienen in: Supportive Care in Cancer 1/2013

01.01.2013 | Original Article

A cross-sectional study of constipation and laxative use in advanced cancer patients: insights for revision of current practice

verfasst von: Chung Wah Cheng, Annie OL Kwok, Zhao Xiang Bian, Doris MW Tse

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to evaluate the bowel habit and laxative use in advanced cancer patients with constipation in palliative care unit.

Methods

It was a cross-sectional study using a self-designed questionnaire.

Results

A total of 225 patients were analysed. Among all patients, 92.0 % (207 patients) had any intervention for relief of constipation, including laxatives, suppositories, enemas, digital evacuation and Chinese herbal medicine, and 65.3 % (147 patients) were on laxatives prescribed by our doctors. The severity of constipation as assessed by the constipation visual analogue scale (CVAS) (0–7, 7 = most severe) was reported as no constipation (0–1) in 19.6 % of patients, constipation (2–4) in 50.7 % and severe constipation (5–7) in 29.8 %. More patients with severe constipation, as compared with patients with constipation and no constipation, reported inadequate pushing force (83.6 vs. 47.4 vs. 6.8 %), sense of incomplete defecation (40.3 vs. 14.9 vs. 6.8 %) and difficult defecation (58.2 vs. 26.3 vs. 0 %), all p < 0.001, but there was no difference in stool types as assessed by Bristol Stool Scale (p = 0.303). Patients not on opioids, as compared with patients on strong opioids, had similar CVAS scores and description of constipation but had least laxatives prescribed (60.2 vs. 78.9 %, p = 0.012).

Conclusion

Evaluation of constipation should not rely on stool form or consistency alone, and patient's description of constipation is worth consideration. Constipation is also a problem in patients not on opioids and more attention is required. A revisit to existing guidelines is needed.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Potter J, Hami F, Bryan T, Quigley C (2003) Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med 17:310–314PubMedCrossRef Potter J, Hami F, Bryan T, Quigley C (2003) Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med 17:310–314PubMedCrossRef
2.
Zurück zum Zitat Curtis EB, Krech R, Walsh TD (1991) Common symptoms in patients with advanced cancer. J Palliat Care 7:25–29PubMed Curtis EB, Krech R, Walsh TD (1991) Common symptoms in patients with advanced cancer. J Palliat Care 7:25–29PubMed
3.
Zurück zum Zitat Fallon MT (1999) Constipation in cancer patients: prevalence, pathogenesis, and cost-related issues. Eur J Pain 3:3–7CrossRef Fallon MT (1999) Constipation in cancer patients: prevalence, pathogenesis, and cost-related issues. Eur J Pain 3:3–7CrossRef
4.
Zurück zum Zitat Mancini I, Bruera E (1998) Constipation in advanced cancer patients. Support Care Cancer 6:356–364PubMedCrossRef Mancini I, Bruera E (1998) Constipation in advanced cancer patients. Support Care Cancer 6:356–364PubMedCrossRef
5.
Zurück zum Zitat Clemens KE, Klaschik E (2008) Management of constipation in palliative care patients. Curr Opin Support Palliat Care 2:22–27PubMedCrossRef Clemens KE, Klaschik E (2008) Management of constipation in palliative care patients. Curr Opin Support Palliat Care 2:22–27PubMedCrossRef
6.
Zurück zum Zitat Sykes NP (1998) The relationship between opioid use and laxative use in terminally ill cancer patients. Palliat Med 12:375–382PubMedCrossRef Sykes NP (1998) The relationship between opioid use and laxative use in terminally ill cancer patients. Palliat Med 12:375–382PubMedCrossRef
7.
Zurück zum Zitat Droney J, Ross J, Gretton S, Welsh K, Sato H, Riley J (2008) Constipation in cancer patients on morphine. Support Care Cancer 16:453–459PubMedCrossRef Droney J, Ross J, Gretton S, Welsh K, Sato H, Riley J (2008) Constipation in cancer patients on morphine. Support Care Cancer 16:453–459PubMedCrossRef
8.
Zurück zum Zitat Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Gootjes JR, Nabal M, Noguera A, Ripamonti C, Zucco F, Zuurmond WW, European Consensus Group on Constipation in Palliative Care (2008) The management of constipation in palliative care: clinical practice recommendations. Palliat Med 22:796–807PubMedCrossRef Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Gootjes JR, Nabal M, Noguera A, Ripamonti C, Zucco F, Zuurmond WW, European Consensus Group on Constipation in Palliative Care (2008) The management of constipation in palliative care: clinical practice recommendations. Palliat Med 22:796–807PubMedCrossRef
9.
Zurück zum Zitat Librach SL, Bouvette M, De Angelis C, Farley J, Oneschuk D, Pereira JL, Syme A, Canadian Consensus Development Group for Constipation in Patients with Advanced Progressive Illness (2010) Consensus recommendations for the management of constipation in patients with advanced, progressive illness. J Pain Symptom Manage 40:761–773PubMedCrossRef Librach SL, Bouvette M, De Angelis C, Farley J, Oneschuk D, Pereira JL, Syme A, Canadian Consensus Development Group for Constipation in Patients with Advanced Progressive Illness (2010) Consensus recommendations for the management of constipation in patients with advanced, progressive illness. J Pain Symptom Manage 40:761–773PubMedCrossRef
11.
Zurück zum Zitat Cheng Cw, Kwok AO, Bian Zx, Tse DM (2012) The quintessence of traditional Chinese medicine: syndrome and its distribution among advanced cancer patients with constipation. Evid. Based Complement Altern Med. doi:10.1155/2012 Cheng Cw, Kwok AO, Bian Zx, Tse DM (2012) The quintessence of traditional Chinese medicine: syndrome and its distribution among advanced cancer patients with constipation. Evid. Based Complement Altern Med. doi:10.​1155/​2012
12.
Zurück zum Zitat Lewis SJ, Heaton KW (1997) Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32:920–924PubMedCrossRef Lewis SJ, Heaton KW (1997) Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32:920–924PubMedCrossRef
13.
Zurück zum Zitat Goodman M, Low J, Wilkinson S (2005) Constipation management in palliative care: a survey of practices in the United Kingdom. J Pain Symptom Manage 29:238–244PubMedCrossRef Goodman M, Low J, Wilkinson S (2005) Constipation management in palliative care: a survey of practices in the United Kingdom. J Pain Symptom Manage 29:238–244PubMedCrossRef
14.
Zurück zum Zitat Saad RJ, Rao SS, Koch KL, Kuo B, Parkman HP, McCallum RW, Sitrin MD, Wilding GE, Semler JR, Chey WD (2010) Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls. Am J Gastroenterol 105:403–411PubMedCrossRef Saad RJ, Rao SS, Koch KL, Kuo B, Parkman HP, McCallum RW, Sitrin MD, Wilding GE, Semler JR, Chey WD (2010) Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls. Am J Gastroenterol 105:403–411PubMedCrossRef
15.
Zurück zum Zitat Brown L, Lawrie I, D'Sa VB, Wilcox S, Bennett M (2006) Constipation: patient perceptions compared to diagnostic tools. Palliat Med 20:717–718PubMedCrossRef Brown L, Lawrie I, D'Sa VB, Wilcox S, Bennett M (2006) Constipation: patient perceptions compared to diagnostic tools. Palliat Med 20:717–718PubMedCrossRef
16.
Zurück zum Zitat Laugsand EA, Kaasa S, de Conno F, Hanks G, Klepstad P, Research Steering Committee of the EAPC (2009) Intensity and treatment of symptoms in 3,030 palliative care patients: a cross-sectional survey of the EAPC Research Network. J Opioid Manag 5:11–21PubMed Laugsand EA, Kaasa S, de Conno F, Hanks G, Klepstad P, Research Steering Committee of the EAPC (2009) Intensity and treatment of symptoms in 3,030 palliative care patients: a cross-sectional survey of the EAPC Research Network. J Opioid Manag 5:11–21PubMed
17.
Zurück zum Zitat Wee B, Adams A, Thompson K, Percival F, Burslem K, Jobanputra M (2010) How much does it cost a specialist palliative care unit to manage constipation in patients receiving opioid therapy? J Pain Symptom Manage 39:644–654PubMedCrossRef Wee B, Adams A, Thompson K, Percival F, Burslem K, Jobanputra M (2010) How much does it cost a specialist palliative care unit to manage constipation in patients receiving opioid therapy? J Pain Symptom Manage 39:644–654PubMedCrossRef
Metadaten
Titel
A cross-sectional study of constipation and laxative use in advanced cancer patients: insights for revision of current practice
verfasst von
Chung Wah Cheng
Annie OL Kwok
Zhao Xiang Bian
Doris MW Tse
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1504-x

Weitere Artikel der Ausgabe 1/2013

Supportive Care in Cancer 1/2013 Zur Ausgabe

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

ASS schützt nicht vor Brustkrebsrezidiven

02.05.2024 Mammakarzinom Nachrichten

Nützt nichts und ist vielleicht sogar schädlich: In einer Phase-3-Studie konnten täglich 300 mg ASS keine Brustkrebsrezidive bei Frauen vermeiden, die ein hohes Risiko für eine Tumorrückkehr aufwiesen. Tendenziell traten unter ASS sogar häufiger Rezidive auf als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.